ArticleJournal of cheminformatics2026
ProQSAR: A modular and reproducible framework for small-data QSAR modeling with fit-and-use models.
Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundQuantitative structure-activity relationship (QSAR) models are central to computer-aided drug discovery and predictive toxicology, but practical adoption is often impeded by ad-hoc tooling, inconsistent validation protocols, and poor reproducibility.
objectiveWe introduce ProQSAR, a modular, reproducible workbench that formalizes end-to-end QSAR development while permitting independent use of each component.
methodsProQSAR composes interchangeable modules for standardization, feature generation, splitting (including scaffold- and cluster-aware splits), preprocessing, outlier handling, scaling, feature selection, model training and tuning, statistical comparison, conformal calibration, and applicability-domain assessment. The pipeline can run end-to-end to produce versioned artifact bundles (serialized models) and analyst-oriented reports suitable for deployment and audit.
resultsOn representative MoleculeNet benchmarks evaluated under Bemis-Murcko scaffold split, ProQSAR attains state-of-the-art descriptor-based performance: the lowest mean RMSE across the regression suite (ESOL, FreeSolv, Lipophilicity; mean RMSE AVAILABILITY: ProQSAR is released on PyPI, Conda, and Docker Hub; all releases embed full provenance (parameters, package versions, checksums) to ensure reproducibility. SCIENTIFIC CONTRIBUTION: ProQSAR (i) enforces best-practice, group-aware validation together with formal statistical comparisons across models, (ii) integrates calibrated uncertainty quantification (cross-conformal prediction) and applicability-domain diagnostics for interpretable, risk-aware predictions, and (iii) exposes both a composable developer API and a one-click pipeline that generates deployment-ready artifacts and human-readable reports, demonstrated on representative benchmarks.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.